Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (29 ops.)
Latest filing published 09 Apr 2026 for Ovid Therapeutics Inc., €39k. Read the official filing
Filing timeline
BuySaleKevin Joseph Fitzgerald
Insider track record
Disclosed buys
0
Disclosed sells
29
T+90 hit rate
83%
T+90 mean return
+9.6%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Kevin Joseph Fitzgerald: trading record in brief
Kevin Joseph Fitzgerald has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Alnylam Pharmaceuticals, Inc. and Ovid Therapeutics Inc. The record holds 43 filings, for trades running from 24 June 2024 to 7 April 2026.
The open-market record consists of 29 sales worth €2.1M, with no purchase. Other entries cover 12 share grants and 2 option exercises. Since January 2026: no purchases and 3 sales on the market.
The latest filing, published on 9 April 2026, reports a share grant of €39k in Ovid Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kevin Joseph Fitzgerald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
17,578 shares@ US$2.56100.0% of flowCommon StockSEC:0001886431-26-000004:0
158 shares0Common StockSEC:0001735276-26-000032:0
4,000 shares0Common StockSEC:0001735276-26-000026:0
1,959 shares@ US$310.080818.7% of flowCommon StockSEC:0001735276-26-000026:1
2,041 shares@ US$331.960620.9% of flowCommon StockSEC:0001735276-26-000026:2
3,800 shares0Common StockSEC:0001735276-26-000011:0
8,161 shares@ US$119.1323.4% of flowCommon StockSEC:0001735276-25-000123:0
2,102 shares0Common StockSEC:0001735276-25-000114:0
2,851 shares0Common StockSEC:0001735276-25-000088:0
39 shares@ US$447.980.5% of flowCommon StockSEC:0001735276-25-000088:1
90 shares@ US$449.921.3% of flowCommon StockSEC:0001735276-25-000088:2
39 shares@ US$450.920.6% of flowCommon StockSEC:0001735276-25-000088:3
103 shares@ US$451.991.5% of flowCommon StockSEC:0001735276-25-000088:4
329 shares@ US$452.964.7% of flowCommon StockSEC:0001735276-25-000088:5
543 shares@ US$454.047.7% of flowCommon StockSEC:0001735276-25-000088:6
241 shares@ US$454.843.4% of flowCommon StockSEC:0001735276-25-000088:7
12 shares@ US$455.820.2% of flowCommon StockSEC:0001735276-25-000088:8
7,763 shares0Common StockSEC:0001735276-25-000077:0
3,871 shares0Common StockSEC:0001735276-25-000034:0
27 shares@ US$236.510.2% of flowCommon StockSEC:0001735276-25-000019:0
2,103 shares0Common StockSEC:0001735276-25-000010:0
145 shares@ US$252.501.3% of flowCommon StockSEC:0001735276-25-000010:1
164 shares@ US$253.371.5% of flowCommon StockSEC:0001735276-25-000010:2
110 shares@ US$254.351.0% of flowCommon StockSEC:0001735276-25-000010:3
47 shares@ US$255.560.4% of flowCommon StockSEC:0001735276-25-000010:4
25 of 41 declarations
